Rapid Etiological Classification of Meningitis by NMR Spectroscopy Based on Metabolite Profiles and Host Response
暂无分享,去创建一个
Ray L. Somorjai | Uwe Himmelreich | Tania C. Sorrell | Brion Dolenko | Richard Malik | Heide-Marie Daniel | R. Somorjai | B. Dolenko | U. Himmelreich | H. Daniel | T. Sorrell | R. Malik | Till Kühn | T. Kühn | T. C. Sorrell | R. Somorjai | Heide-Marie Daniel | Uwe Himmelreich | Richard Malik | Till Kühn
[1] R. Fishman. Cerebrospinal Fluid in Diseases of the Nervous System , 1992 .
[2] R. Mortishire-Smith,et al. Metabolic profiling of rodent biological fluids via 1H NMR spectroscopy using a 1 mm microlitre probe. , 2002, The Analyst.
[3] U. Himmelreich,et al. Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study. , 2001, Radiology.
[4] J. Selbig,et al. Parallel analysis of transcript and metabolic profiles: a new approach in systems biology , 2003, EMBO reports.
[5] J. E. Bennett,et al. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2014 .
[6] L. Mariey,et al. Discrimination, classification, identification of microorganisms using FTIR spectroscopy and chemometrics , 2001 .
[7] U. Himmelreich,et al. NMR spectroscopic determination of microbiological profiles in infectious diseases. , 2004 .
[8] W. Binder,et al. Dexamethasone in adults with bacterial meningitis. , 2003, The New England journal of medicine.
[9] J. Vion-Dury,et al. CSF and serum metabolic profile of patients with Huntington's chorea: A study by high resolution proton NMR spectroscopy and HPLC , 1993, Neuroscience Letters.
[10] James P. Malone,et al. Comparative Proteomic Analysis of Intra- and Interindividual Variation in Human Cerebrospinal Fluid*S , 2005, Molecular & Cellular Proteomics.
[11] Royston Goodacre,et al. Metabolic footprinting as a tool for discriminating between brewing yeasts , 2007, Yeast.
[12] Francisco Azuaje,et al. Artificial Intelligence Methods And Tools For Systems Biology , 2004, Computational Biology.
[13] M. Kenward,et al. An Introduction to the Bootstrap , 2007 .
[14] P. Wright,et al. Sensitivity improvement in proton-detected two-dimensional heteronuclear correlation NMR spectroscopy , 1991 .
[15] Ian D. Wilson,et al. HIGH RESOLUTION PROTON MAGNETIC RESONANCE SPECTROSCOPY OF BIOLOGICAL FLUIDS , 1989 .
[16] D. Kell,et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations , 2001, Nature Biotechnology.
[17] D. Desiderio,et al. Human cerebrospinal fluid peptidomics. , 2005, Journal of mass spectrometry : JMS.
[18] G. Pfyffer,et al. Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens , 1996, Journal of clinical microbiology.
[19] Julian L Griffin,et al. Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern‐recognition 1H NMR study , 2005, NMR in biomedicine.
[20] R. Somorjai,et al. Distinguishing normal from rejecting renal allografts: application of a three—stage classification strategy to MR and IR spectra of urine , 2002 .
[21] P. Peduzzi,et al. Community-Acquired Bacterial Meningitis: Risk Stratification for Adverse Clinical Outcome and Effect of Antibiotic Timing , 1998, Annals of Internal Medicine.
[22] P. Demirev,et al. Characterization of intact microorganisms by MALDI mass spectrometry. , 2001, Mass spectrometry reviews.
[23] I. Tominaga,et al. Proton magnetic resonance spectroscopy of cerebrospinal fluid as an aid in neurological diagnosis. , 1994, Biological & pharmaceutical bulletin.
[24] Jimmy D Bell,et al. High resolution proton nuclear magnetic resonance studies of human cerebrospinal fluid. , 1987, Clinical science.
[25] R L Somorjai,et al. Near‐optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra , 1998, NMR in biomedicine.
[26] Daniel Marek,et al. High-resolution capillary tube NMR. A miniaturized 5-microL high-sensitivity TXI probe for mass-limited samples, off-line LC NMR, and HT NMR. , 2002, Analytical chemistry.
[27] D. Kell,et al. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting , 2003, Nature Biotechnology.
[28] U. Himmelreich,et al. Identification of metabolites of importance in the pathogenesis of pulmonary cryptococcoma using nuclear magnetic resonance spectroscopy. , 2003, Microbes and infection.
[29] B. Dolenko,et al. Identification of Staphylococcus aureus brain abscesses: rat and human studies with 1H MR spectroscopy. , 2005, Radiology.
[30] R. Somorjai,et al. Rapid Identification of Candida Species by Using Nuclear Magnetic Resonance Spectroscopy and a Statistical Classification Strategy , 2003, Applied and Environmental Microbiology.
[31] P. Lewczuk,et al. The amyloid-β (Aβ) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Aβ peptide , 2003 .
[32] Muireann Coen,et al. Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] Martijn Weisfelt,et al. Clinical features and prognostic factors in adults with bacterial meningitis. , 2004, The New England journal of medicine.
[34] Willem Boogerd,et al. MALDI-TOF Mass Spectrometry Analysis of Cerebrospinal Fluid Tryptic Peptide Profiles to Diagnose Leptomeningeal Metastases in Patients with Breast Cancer* , 2005, Molecular & Cellular Proteomics.
[35] W. Dunn,et al. Measuring the metabolome: current analytical technologies. , 2005, The Analyst.
[36] W. Wood,et al. Acute meningitis. , 1947, The American journal of medicine.
[37] J. Heitman. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2000 .
[38] D. Naumann,et al. Identification of medically relevant microorganisms by vibrational spectroscopy. , 2002, Journal of microbiological methods.
[39] Murray E. Alexander,et al. A Data-Driven, Flexible Machine Learning Strategy for the Classification of Biomedical Data , 2004, Artificial Intelligence Methods And Tools For Systems Biology.
[40] Katharina Buerger,et al. Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease. , 2005, Combinatorial chemistry & high throughput screening.
[41] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .
[42] A Heerschap,et al. Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. , 1995, Clinical chemistry.
[43] J. Vion-Dury,et al. Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy. , 1998, Brain research. Brain research protocols.
[44] Abhishek Gupta,et al. Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children , 2005, NMR in biomedicine.
[45] Cheng-Hsien Lu,et al. Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors , 2002, Clinical Neurology and Neurosurgery.